Liriodendrin, ameliorates hypertension by calcium channel blockade and enhancing enos expression in wistar rats
Автор: Anjali B.Tajanpure, Vandana S. Nade, Laxman A. Kawale
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 20, 2021 года.
Бесплатный доступ
Introduction: Hypertension is found to be the prime cause of death worldwide in spite of a number of available treatments which suggests that there is a need of discovering new lead molecules that would be more effective to treat cardiovascular disease (CVD). Liriodendrin, the lignan phytoconstituent possesses potential pharmacological effects. Literature survey suggests that liriodendrin could be effective in mitigating hypertension considering its structural similarity with reported cardiovascular protective drugs. Hence liriodendrin is investigated to reveal its mechanism of actions to support its antihypertensive property. Methods: Hypertension was induced in male wistar rats with DOCA salt. Hypertensive rats were treated with liriodendrin for 4 weeks. Blood pressure, heart rate, body weight, lipid profile, serum nitrite levels, vascular reactivity to various catecholamines, in-vitro calcium channel blocking assays, antioxidant assay, determination of aortic calcium level, endothelial function, expression of eNOS analysis were studied. Result: Liriodendrin was found safe orally up to 2000 mg/kg. It showed a significant decrease in heart rate, blood pressure and mean arterial pressure. In-vitro study on the isolated rat aorta revealed the calcium channel blocking potential of liriodendrin. Vascular reactivity to various catecholamines was normalized. Vascular endothelium was significantly protected by the enhanced release of nitric oxide and eNOS expression by the western blot technique. Oxidative stress was also significantly reduced. Conclusion: Liriodendrin was found to be beneficial in hypertension as it produced vasorelaxation by blocking calcium channels, enhancing nitric oxide release, and reducing oxidative stress. Thus, liriodendrin may be useful to relieve hypertension and cardiovascular complications.
DOCA, Hypertension, Endothelial dysfunction, Oxidative stress, Liriodendrin
Короткий адрес: https://sciup.org/148322433
IDR: 148322433 | DOI: 10.18137/cardiometry.2021.20.4759
Список литературы Liriodendrin, ameliorates hypertension by calcium channel blockade and enhancing enos expression in wistar rats
- Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies from 90 Countries. Circulation. 2016; 134(6):441–50 DOI: 10.1161/CIRCULATIONAHA.115.018912
- Paramore LC, Halpern MT, Lapuerta P, Hurley JS, Frost FJ, Fairchild DG, Bates D. Impact of poorly controlled hypertension on healthcare resource utilization and cost. The American journal of managed are.2001;7(4): 389–398 PMID: 11310193.
- Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, Carey RM. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension.2008; 51(6):1403–1419 DOI: 10.1161/CIRCULATIONAHA. 108.18914.1
- Sircar NN. Medicinal plants. The Eastern Pharmacist. 1982; 29(291): 49-52.
- De Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: The Framingham study. J Nutr.2002; 132(2): 276-282 DOI: 10.1093/jn/132.2.276.
- Valsta LM, Kilkkinen A, Mazur W. Phyto-oestrogen database of foods and average intake in Finland. Br J Nutr. 2003; 89 Suppl 1: S31-38. DOI: 10.1079/BJN2002794.
- Zhang J, Chen J, Liang Z, Zhao C. New lignans, their biological activities. Chem. Biodivers.2014; 11:1–54 DOI: 10.1002/cbdv.201100433.
- Rowland I, Faughnan M, Hoey L, Wähälä K, Williamson G & Cassidy A. Bioavailability of phyto-oestrogens. The British journal of nutrition.2003; 89 Suppl 1: S45–S58 DOI: 10.1079/BJN2002796.
- Seth C. Yoder, Samuel M. Lancaster, Meredith A.J. Hullar, Johanna W. Lampe. Chapter.Gut Microbial Metabolism of Plant Lignans: Influence on Human Health, Editor(s): Kieran Tuohy, Daniele Del Rio, Diet-Microbe Interactions in the Gut, Academic Press. 2015; 103-117.
- Zhou F, Furuhashi K, Son MJ, Toyozaki M, Yoshizawa F, Miura Y & Yagasaki, K. Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology.2017;69(3):493–502 DOI: 10.1007/s10616-016-9965-2
- Martínez-Luis S, Pérez-Vásquez A, & Mata R. Natural products with calmodulin inhibitor properties. Phytochemistry.2007; 68(14): 1882–1903 DOI: 10.1016/j.phytochem.2007;02.025.
- Lee IS, Jung, KY, Oh SR, Park SH, Ahn KS, & Lee HK. Structure-Activity Relationships of Lignans from Schisandrachinensis as Platelet Activating Factor Antagonists. Biological & Pharmaceutical Bulletin.1999; 22(3): 265–267 DOI: 10.1248/bpb.22.265.
- Hosokawa A, Sumino M, Nakamura T, Yano S, Sekine T, Ruangrungsi N, Ikegami F. A New Lignan from Balanophora abbreviata and Inhibition of Lipopolysaccharide (LPS)-induced Inducible Nitric Oxide Synthase (iNOS) Expression. Chemical & pharmaceutical bulletin. 2004; 52(10):1265–1267 DOI:10.1248/cpb.52.1265.
- UMEZAWA Toshiaki .Wood research: bulletin of the Wood Research Institute Kyoto University. 2003; 90: 27-110
- Skidmore-Roth, L. Mosby’s Handbook of Herbs & Natural Supplements - E-Book. United States: Elsevier Health Sciences.2009: 124 ISBN: 9780323066495.
- WU XL, WANG YY, CHENG J, ZHAO YY. Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta. Acta Pharmacologica Sinica. 2006; 27:1007-1012 DOI: 10.1111/j.1745-7254.2006.00349.x.
- Vogel GH.Drug Discovery and Evaluation, 2nd ed. Berlin, Heidelberg, Springer-Verlag. 2002: 176 ISBN 978-3-540-70995-4.
- Malkoff J.Non-invasive blood pressure for mice and rats. Kent Scientific Corporation.2004:1-4.
- Grisham MB, Johnson GG, Lancaster JR. Jr Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol.1996;268:237–46 DOI: 10.1016/s0076-6879(96)68026-4.
- Balaraman R, Hingorani N , Rathod SP. Studies on the antihypertensive effect of abana in rats. Indian J Pharmacol.1993; 25: 209-14.
- Celermajer DS.Endothelial Dysfunction: Does It Matter? Is It Reversible? Journal of the American College of Cardiology.1997;30(2):325–333 DOI: 10.1016/s0735-1097(97)00189-7.
- Zeydanli EN, Kandilci HB & Turan B. Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats. Cardiovascular toxicology.2011; 11(2):134–147 DOI: 10.1007/s12012-011-9107-1.
- Desmawati D and Sulastri D.Phytoestrogens and Their Health Effect. Maced J Med Sci.2019;7(3): 495- 499 DOI: 10.3889/oamjms.2019.086.
- Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci.1979; 76: 4350–4354 DOI: 10.1073/pnas.76.9.4350.
- Felaco M, Grilli A, Gorbunov N. Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions. Biochimica et Biophysica Acta.2000;1524 (2-3): 203- 211 DOI: 10.1016/s0304-4165(00)00159-8.
- Luck H.Catalase. In: Bergmeyer, H.U., Ed., Method of Enzymatic Analysis, Academic Press, New York and London.1965:885-894 DOI:10.1016/B978-0-12-395630-9.50158-4.
- Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clinica chimica acta; international journal of clinical chemistry.1991;196 (2-3) :143–151 DOI: 10.1016/0009-8981(91)90067-m.
- Kono Y.Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of biochemistry and biophysics.1978;186 (1):189–195 DOI: 10.1016/0003-9861(78)90479-4.
- Wills ED. Mechanisms of lipid peroxide formation in animal tissues. The Biochemical journal.1966; 99 (3):667–676 DOI: 10.1042/bj0990667.
- Pathak RJ, Chatterjee A, Singh SP and Sinha RP. Detection of Reactive Oxygen Species (ROS) in Cyanobacteria Using the Oxidant-sensing Probe 2’,7’-Dichlorodihydrofluorescein Diacetate (DCFH-DA). Bio-protocol.2017; 7(17): e2545 DOI: 10.21769/Bio-Protoc.2545
- Peñalvo JL, Heinonen SM, Aura AM, Adlercreutz H. Dietary sesamin is converted to enterolactone in humans. The Journal of nutrition.2005; 135(5):1056–1062 DOI:10.1093/jn/135.5.1056.
- Khurana S, Venkataraman K, Hollingsworth A, Piche M & Tai T. Polyphenols: Benefits to the Cardiovascular System in Health and in Aging. Nutrients. 2013; 5(10):3779–3827 DOI: 10.3390/nu5103779.
- Pichavaram P, Murugesan S & Boobalan R. The flavonoid morin restores blood pressure and lipid metabolism in DOCA-salt hypertensive rats, Redox Report. 2012; 17(4): 167-175 doi: 10.1179/1351000212Y.0000000015.
- Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol.1998;81:7–12 DOI: 10.1016/s0002-9149(98)00031-9.
- Touyz RM, Milne FJ. Alterations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension. J Hypertens.1995; 8: 867-74. DOI: 10.1097/00004872-199508000-00007.
- Downey RM, Liao P, Millson EC, Quyyumi AA, Sher S, Park J. Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease. American journal of physiology. Renal physiology. 2017; 312(5): F917–F924 DOI: 10.1152/ajprenal.00603.2016.
- Forstermann U, & Sessa, WC. Nitric oxide synthases: regulation and function. European Heart Journal.2011;33(7): 829–837 DOI: 10.1093/eurheartj/ehr304
- Silva GC, Silva JF, Diniz TF, Lemos VS & Cortes SF Endothelial dysfunction in DOCA-salt-hypertensive mice: role of neuronal nitric oxide synthase-derived hydrogen peroxide. Clinical science. 2016; 130(11):895–906 DOI: 10.1042/CS20160062.
- Ignarro J, Fukuto J, Griscavage J, Rogers N and Byrns R. Proc. Natl. Acad. Sci.1993; 90: 8103 DOI: 10.1073/pnas.90.17.8103.
- Marietta, M .Chem. Res. ToxicoL. 1988; 1: 249 DOI:10.1007/978-3-319-20669-1.
- Youn, Ji Youn & Wang, Ting & Blair, John & Laude, Karine & Oak, Jeong-Ho & McCann, Louise & Harrison, David & Cai, Hua. Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension. Am J Physiol Heart Circ Physiol. 2012; 302(11):H2243-H2249 DOI: 10.1152/ajpheart.00835.2011.
- OECD (2008), Test No. 425: Acute Oral Toxicity: Up-and-Down Procedure, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris DOI:10.1787/9789264071049-en.
- Godfraind T. Discovery and Development of Calcium Channel Blockers. Frontiers in pharmacology. 2017; 8: 286 DOI:10.3389/fphar.2017.00286.